A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs–monitoring of therapeutic drug efficacy as a case study
PLOS Neglected Tropical Diseases · 2023
DOI: 10.1371/journal.pntd.0011071 ↗Kurz gefasst
Klinische Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Luc E Coffeng und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Helminthiasis, Helminths. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Bill and Melinda Gates Foundation, Schistosomiasis Control Initiative.
Abstract (Originalsprache)
Background
Soil-transmitted helminth (STH) control programs currently lack evidence-based recommendations for cost-efficient survey designs for monitoring and evaluation. Here, we present a framework to provide evidence-based recommendations, using a case study of therapeutic drug efficacy monitoring based on the examination of helminth eggs in stool.
Methods
We performed an in-depth analysis of the operational costs to process one stool sample for three diagnostic methods (Kato-Katz, Mini-FLOTAC and FECPAK G2 ). Next, we performed simulations to determine the probability of detecting a truly reduced therapeutic efficacy for different scenarios of STH species ( Ascaris lumbricoides , Trichuris trichiura and hookworms), pre-treatment infection levels, survey design (screen and select ( SS ); screen, select and retest ( SSR ) and no selection ( NS )) and number of subjects enrolled (100–5,000). Finally, we integrated the outcome of the cost assessment into the simulation study to estimate the total survey costs and determined the most cost-efficient survey design. Principal findings Kato-Katz allowed for both the highest sample throughput and the lowest cost per test, while FECPAK G2 required both the most laboratory time and was the most expensive. Counting of eggs accounted for 23% (FECPAK G2 ) or ≥80% (Kato-Katz and Mini-FLOTAC) of the total time-to-result. NS survey designs in combination with Kato-Katz were the most cost-efficient to assess therapeutic drug efficacy in all scenarios of STH species and endemicity. Conclusions/significance We confirm that Kato-Katz is the fecal egg counting method of choice for monitoring therapeutic drug efficacy, but that the survey design currently recommended by WHO ( SS ) should be updated. Our generic framework, which captures laboratory time and material costs, can be used to further support cost-efficient choices for other important surveys informing STH control programs. In addition, it can be used to explore the value of alternative diagnostic techniques, like automated egg counting, which may further reduce operational costs. Trial Registration ClinicalTrials.gov NCT03465488
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.
- Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- Department of Veterinary and Animal Sciences, University of Copenhagen, Denmark.
- National Health System, Turin, Italy.
- Laboratory Division, Public Health Laboratory-Ivo de Carneri, Chake Chake, United Republic of Tanzania.
ORCID-Profile: Luc E Coffeng
Förderung
- World Health Organization
- Bill and Melinda Gates Foundation
- Schistosomiasis Control Initiative
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Flemish Research Foundation
- Partnership for Child Development
- Children’s Investment Fund Foundation
- The End Neglected Diseases Fund
Zitieren
APA
Coffeng, L. E., Vlaminck, J., Cools, P., Denwood, M., Albonico, M., Ame, S. M., Ayana, M., Dana, D., Cringoli, G., de Vlas, S. J., Fenwick, A., French, M., Kazienga, A., Keiser, J., Knopp, S., Leta, G., Matoso, L. F., Maurelli, M. P., Montresor, A., …, & Levecke, B. (2023). A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs–monitoring of therapeutic drug efficacy as a case study. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011071
Vancouver
Coffeng LE, Vlaminck J, Cools P, Denwood M, Albonico M, Ame SM, et al. A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs–monitoring of therapeutic drug efficacy as a case study. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011071
BibTeX
@article{Coffeng2023,
author = {Coffeng, Luc E and Vlaminck, Johnny and Cools, Piet and Denwood, Matthew and Albonico, Marco and Ame, Shaali M and Ayana, Mio and Dana, Daniel and Cringoli, Giuseppe and de Vlas, Sake J and Fenwick, Alan and French, Michael and Kazienga, Adama and Keiser, Jennifer and Knopp, Stefanie and Leta, Gemechu and Matoso, Leonardo F and Maurelli, Maria P and Montresor, Antonio and Mirams, Greg and Mekonnen, Zeleke and Corrêa-Oliveira, Rodrigo and Pinto, Simone A and Rinaldi, Laura and Sayasone, Somphou and Steinmann, Peter and Thomas, Eurion and Vercruysse, Jozef and Levecke, Bruno},
title = {A general framework to support cost-efficient fecal egg count methods and study design choices for large-scale STH deworming programs–monitoring of therapeutic drug efficacy as a case study},
journal = {PLOS Neglected Tropical Diseases},
year = {2023},
doi = {10.1371/journal.pntd.0011071}
}
EUVIMED